Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-01405 |
Kallikrein 5/KLK5 Protein, Human, Recombinant (His)
Stratum Corneum Tryptic Enzyme,Kallikrein-Like Protein 2,KLK... |
Human | HEK293 Cells |
Kallikrein 5/KLK5 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 40 KDa and the accession number is Q9Y337. | |||
TMPH-03506 |
IpaB Protein, Shigella flexneri, Recombinant (His)
62 kDa antigen,sctE,Type 3 secretion system translo... |
Shigella flexneri | E. coli |
IpaB Protein, Shigella flexneri, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 40.6?kDa and the accession number is P18011. | |||
TMPH-03718 |
YopB Protein, Yersinia enterocolitica, Recombinant (His)
Type 3 secretion system translocon protein SctE, |
Yersinia enterocolitica | E. coli |
Plays a role in virulence. | |||
TMPK-01158 |
Kallikrein 5/KLK5 Protein, Mouse, Recombinant (His)
SCTE,KLKL2,KLK5,KLK-L2,Klnc,Kallikrein c |
Mouse | HEK293 Cells |
The inhibition of kallikrein 5 (KLK5) has been identified as a potential strategy for treatment of the genetic skin disorder Netherton syndrome, in which loss-of-function mutations in the SPINK5 gene lead to down-regulation of the endogenous inhibitor LEKTI-1 and profound skin-barrier defects with severe allergic manifestations. To aid in the development of a medicine for this target, an X-ray crystallographic system was developed to facilitate fragment-guided chemistry and knowledge-based drug-... |